<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02513784</url>
  </required_header>
  <id_info>
    <org_study_id>AAAP4553</org_study_id>
    <nct_id>NCT02513784</nct_id>
  </id_info>
  <brief_title>Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome</brief_title>
  <acronym>Mouthwash</acronym>
  <official_title>Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, open-label pilot study to assess whether treatment with chlorhexidine
      mouthwash can alter the esophageal and gastric cardia microbiome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients scheduled for upper endoscopy for clinical indications will be randomized to 3 weeks
      of either no treatment or use of twice daily chlorhexidine mouthwash leading up to the
      endoscopy. There will be 2-3 study visits, at Day 0 and Day 21, and for those subjects in the
      mouthwash arm, a final visit 1-2 weeks following the Day 21 visit. Subjects will be required
      to fast overnight prior to the visits on Days 0 and 21.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of F. nucleatum in saliva</measure>
    <time_frame>21 days</time_frame>
    <description>Within individual change in relative abundance of F nucleatum in oral samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference in esophageal F. nucleatum between experimental group and no intervention group</measure>
    <time_frame>21 days</time_frame>
    <description>Comparison of relative abundance of esophageal F. nucleatum in the mouthwash group vs. the no intervention group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Esophageal Adenocarcinoma</condition>
  <condition>Barrett's Esophagus</condition>
  <condition>Reflux Esophagitis</condition>
  <arm_group>
    <arm_group_label>Antibacterial mouthwash</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be randomized to twice daily chlorhexidine gluconate mouthwash for 21 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will be randomized to no intervention for 21 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine gluconate</intervention_name>
    <description>Chlorhexidine gluconate is a germicidal mouthwash that reduces bacteria in the mouth.</description>
    <arm_group_label>Antibacterial mouthwash</arm_group_label>
    <other_name>Peridex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18

          -  Scheduled for upper endoscopy for clinical indications

          -  No allergy or other contraindication to chlorhexidine

        Exclusion Criteria:

          -  Use of proton pump inhibitors or H2 receptor antagonists within 1 month of enrollment.
             Acid suppressant medications raise the gastric pH and can dramatically alter the
             gastric and esophageal microbiome.

          -  History of upper gastrointestinal cancer

          -  History of histologically proven Barrett's esophagus

          -  History of antireflux or bariatric surgery, or other gastric or esophageal surgery

          -  Use of antimicrobial mouthwash within 1 month of enrollment

          -  Use of antibiotics or immunosuppressant medications within 3 months of enrollment

          -  Use of steroid inhalers or nasal sprays within 1 month of enrollment

          -  HIV or other immunosuppressed states or conditions (e.g. active malignancy)

          -  Pregnant or breast feeding

          -  Inability to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julian A. Abrams, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant Professor of Medicine and Epidemiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2015</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Columbia University</investigator_affiliation>
    <investigator_full_name>Julian A Abrams, MD</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Microbiome</keyword>
  <keyword>Esophagus</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Mouthwash</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Esophagitis</mesh_term>
    <mesh_term>Barrett Esophagus</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Esophagitis, Peptic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

